Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial | Synapse

Cite This Study

Schneider et al. (Thu,) studied this question.

synapsesocial.com/papers/69d915cbea2783c07da3bfe1 https://doi.org/https://doi.org/10.1016/s0140-6736(23)00641-4

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Post-Epidemic Chikungunya Disease on Reunion Island: Course of Rheumatic Manifestations and Associated Factors over a 15-Month Period2009 · 413 citations
2Prophylaxis and Therapy for Chikungunya Virus Infection2009 · 241 citations
3Chikungunya Infection in Travelers2006 · 157 citations
4Chikungunya Virus Infections2015 · 86 citations
517DD yellow fever vaccine2013 · 118 citations

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Post-Epidemic Chikungunya Disease on Reunion Island: Course of Rheumatic Manifestations and Associated Factors over a 15-Month Period2009 · 413 citations
2Prophylaxis and Therapy for Chikungunya Virus Infection2009 · 241 citations
3Chikungunya Infection in Travelers2006 · 157 citations
4Chikungunya Virus Infections2015 · 86 citations
517DD yellow fever vaccine2013 · 118 citations